drugset / Trial / NCT03185468
Intervention of Bladder Cancer by CAR-T
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is a Phase I/II and multicenter study designed to evaluate the efficacy and safety of 4SCAR-T cells in participants with locally advanced or metastatic urothelial bladder cancer (UBC) who have no further treatment available.
Timeline
- Start
- 2025-08-01
- Primary completion
- 2028-12-31
- Completion
- 2029-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 4SCAR-FRa | Cell therapy | — | — |
| Subject | 4SCAR-PSMA | Cell therapy | — | — |